학술논문

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Document Type
Article
Source
In The Lancet Gastroenterology & Hepatology November 2016 1(3):196-206
Subject
Primary Research
Articles
Language
ISSN
2468-1253